Skip to main content
Clinical Trials/ITMCTR2000003682
ITMCTR2000003682Not yet recruitingPhase 1

Clinical application of Fuyuan Huoxue Decoction in constipation after operation of osteoporotic thoracolumbar fracture

Yueyang Hospital of Integrated Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine0 sitesStarted: TBDLast updated:

Trial Snapshot

Phase
Phase 1
Status
Not yet recruiting
Sponsor

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional study

Eligibility Criteria

Ages
50 to 80 (—)
Sex
All

Inclusion Criteria

  • a. Those who met the diagnostic criteria of osteoporosis, thoracolumbar compression fracture and constipation;
  • b. Patients with age >= 50 years old and <= 80 years old, with clear consciousness, can cooperate with clinical data collection;
  • c. Patients who had undergone thoracolumbar fracture surgery within one week after fracture;
  • d. If the syndrome type of traditional Chinese medicine is in accordance with the syndrome of blood stasis and qi stagnation of fracture disease, the affected area is painful, and the tongue is dark purple or has ecchymosis, the pulse is stringy and astringent;
  • e. Those who voluntarily participated in the trial and signed the informed consent to enter the study.

Exclusion Criteria

  • a. Combined with spinal cord or other organ injury;
  • b. Patients with a long history of abdominal distension and constipation before injury;
  • c. Patients with severe primary diseases such as heart, brain, liver, kidney and hematopoietic system, and mental diseases;
  • d. Pathological fracture is caused by primary bone tumor, metastatic bone tumor, infection or abnormal endocrine metabolism;
  • e. Menstrual women, pregnant or ready to be pregnant women, lactating women;
  • f. Patients with diabetes mellitus and galactosemia.

Investigators

Sponsor
Yueyang Hospital of Integrated Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine

Similar Trials